| Schedule of Investments Available-for-sale |
Investments available for sale consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of June 30, 2026 |
|
(in thousands) |
|
Amortized Cost |
|
|
Gross Unrealized Gains |
|
|
Gross Unrealized Losses |
|
|
Fair Market Value |
|
Maturity less than 1 year: |
|
|
|
|
|
|
|
|
|
|
|
|
Certificate of deposit |
|
$ |
1,248 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1,248 |
|
Corporate debt securities |
|
|
8,321 |
|
|
|
2 |
|
|
|
(10 |
) |
|
|
8,313 |
|
Commercial paper |
|
|
1,581 |
|
|
|
— |
|
|
|
— |
|
|
|
1,581 |
|
U.S. government agencies |
|
|
644 |
|
|
|
— |
|
|
|
— |
|
|
|
644 |
|
U.S. treasury securities |
|
|
4,397 |
|
|
|
— |
|
|
|
(1 |
) |
|
|
4,396 |
|
Total maturity less than 1 year |
|
|
16,191 |
|
|
|
2 |
|
|
|
(11 |
) |
|
|
16,182 |
|
Maturity 1 to 2 years: |
|
|
|
|
|
|
|
|
|
|
|
|
Corporate debt securities |
|
|
5,606 |
|
|
|
— |
|
|
|
(27 |
) |
|
|
5,579 |
|
U.S. treasury securities |
|
|
3,588 |
|
|
|
— |
|
|
|
(26 |
) |
|
|
3,562 |
|
Total maturity 1 to 2 years |
|
|
9,194 |
|
|
|
— |
|
|
|
(53 |
) |
|
|
9,141 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total short-term investments |
|
$ |
25,385 |
|
|
$ |
2 |
|
|
$ |
(64 |
) |
|
$ |
25,323 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2025 |
|
(in thousands) |
|
Amortized Cost |
|
|
Gross Unrealized Gains |
|
|
Gross Unrealized Losses |
|
|
Fair Market Value |
|
Maturity less than 1 year: |
|
|
|
|
|
|
|
|
|
|
|
|
Certificate of deposit |
|
$ |
143 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
143 |
|
Corporate debt securities |
|
|
23,699 |
|
|
|
18 |
|
|
|
(2 |
) |
|
|
23,715 |
|
Commercial paper |
|
|
413 |
|
|
|
— |
|
|
|
— |
|
|
|
413 |
|
U.S. government agencies |
|
|
2,872 |
|
|
|
4 |
|
|
|
— |
|
|
|
2,876 |
|
U.S. treasury securities |
|
|
4,798 |
|
|
|
2 |
|
|
|
— |
|
|
|
4,800 |
|
Total maturity less than 1 year |
|
|
31,925 |
|
|
|
24 |
|
|
|
(2 |
) |
|
|
31,947 |
|
Maturity 1 to 2 years: |
|
|
|
|
|
|
|
|
|
|
|
|
Corporate debt securities |
|
|
4,940 |
|
|
|
15 |
|
|
|
(1 |
) |
|
|
4,954 |
|
U.S. treasury securities |
|
|
3,919 |
|
|
|
14 |
|
|
|
— |
|
|
|
3,933 |
|
Total maturity 1 to 2 years |
|
|
8,859 |
|
|
|
29 |
|
|
|
(1 |
) |
|
|
8,887 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total short-term investments |
|
$ |
40,784 |
|
|
$ |
53 |
|
|
$ |
(3 |
) |
|
$ |
40,834 |
|
|
| Schedule of Components of Property and Equipment |
Property and equipment consisted of the following:
|
|
|
|
|
|
|
|
|
(in thousands) |
|
As of June 30,
2026 |
|
|
As of December 31,
2025 |
|
Furniture and office equipment |
|
$ |
750 |
|
|
$ |
1,051 |
|
Leasehold improvements |
|
|
2,568 |
|
|
|
2,568 |
|
Laboratory equipment |
|
|
1,426 |
|
|
|
1,426 |
|
Property and equipment, gross |
|
|
4,744 |
|
|
|
5,045 |
|
Less—accumulated depreciation |
|
|
(4,294 |
) |
|
|
(4,467 |
) |
Property and equipment, net |
|
$ |
450 |
|
|
$ |
578 |
|
|
| Schedule of Accrued Liabilities |
Accrued liabilities consisted of the following:
|
|
|
|
|
|
|
|
|
(in thousands) |
|
As of June 30,
2026 |
|
|
As of December 31,
2025 |
|
Clinical trials |
|
$ |
2,146 |
|
|
$ |
3,805 |
|
Accrued compensation |
|
|
3,256 |
|
|
|
2,430 |
|
Unsettled investments payable |
|
|
— |
|
|
|
744 |
|
Research agreements and services |
|
|
331 |
|
|
|
311 |
|
Other accrued liabilities |
|
|
621 |
|
|
|
287 |
|
Total accrued liabilities |
|
$ |
6,354 |
|
|
$ |
7,577 |
|
|